A detailed history of Evergreen Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Evergreen Capital Management LLC holds 9,057 shares of AMGN stock, worth $2.86 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
9,057
Previous 8,832 2.55%
Holding current value
$2.86 Million
Previous $2.51 Million 12.66%
% of portfolio
0.11%
Previous 0.1%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $59,118 - $71,844
225 Added 2.55%
9,057 $2.83 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $134,166 - $161,955
499 Added 5.99%
8,832 $2.51 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $341,359 - $385,094
1,335 Added 19.08%
8,333 $2.4 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $245,543 - $304,849
1,123 Added 19.11%
6,998 $1.88 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $230,340 - $272,372
-1,075 Reduced 15.47%
5,875 $1.3 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $356,070 - $433,990
1,577 Added 29.35%
6,950 $1.68 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $27,941 - $35,503
122 Added 2.32%
5,373 $1.41 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $348,586 - $393,141
1,553 Added 42.0%
5,251 $1.18 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $1.72 Million - $1.92 Million
-7,465 Reduced 66.87%
3,698 $900,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $154,585 - $171,011
705 Added 6.74%
11,163 $2.7 Million
Q4 2021

Mar 11, 2022

SELL
$198.88 - $227.6 $25,058 - $28,677
-126 Reduced 1.19%
10,458 $2.35 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $43,090 - $50,486
203 Added 1.96%
10,584 $2.25 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $277,259 - $307,599
-1,187 Reduced 10.26%
10,381 $2.53 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $11,983 - $13,964
54 Added 0.47%
11,568 $2.88 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $1.8 Million - $2.14 Million
8,302 Added 258.47%
11,514 $2.65 Million
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $6,100 - $6,784
26 Added 0.82%
3,212 $816,000
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $18,000 - $22,089
-91 Reduced 2.78%
3,186 $751,000
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $132,488 - $175,715
-727 Reduced 18.16%
3,277 $664,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $115,418 - $148,352
610 Added 17.97%
4,004 $965,000
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $21,415 - $25,660
-123 Reduced 3.5%
3,394 $657,000
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $64,012 - $75,037
-384 Reduced 9.84%
3,517 $648,000
Q1 2019

May 10, 2019

BUY
$180.87 - $203.88 $90,254 - $101,736
499 Added 14.67%
3,901 $741,000
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $1,784 - $2,082
-10 Reduced 0.29%
3,402 $662,000
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $45,581 - $51,386
246 Added 7.77%
3,412 $707,000
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $24,409 - $27,416
147 Added 4.87%
3,166 $584,000
Q1 2018

May 10, 2018

BUY
$169.43 - $198.0 $229,577 - $268,290
1,355 Added 81.43%
3,019 $515,000
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $280,866 - $313,813
1,664
1,664 $289,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.